Aclarion, Inc.
ACON- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001635077
In the last 90 days, Aclarion, Inc. insiders filed 6 open-market purchases and 0 sales; 15 institutions reported holding it in 13F filings for Q2 2026, worth $332.1K in total; no superinvestor holds it.
Other share classesACONW
13F holders, Q1 2024
Institutional positions in Aclarion, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 7
- −2 vs. Q4 2023
- Shares held
- 272.6K
- −348.8K (−56.1%) vs. Q4 2023
- Total value
- $89.4K
- −$34.6K (−27.9%) vs. Q4 2023
- New holders
- 2
- 1 more added
- Sold out
- 4
- 4 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ACON on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 15 | $332.1K |
| Q1 2026 | 10 | $368.1K |
| Q4 2025 | 8 | $80.2K |
| Q3 2025 | 8 | $168.0K |
| Q2 2025 | 5 | $13.7K |
| Q1 2025 | 6 | $734 |
| Q4 2024 | 9 | $66.4K |
| Q3 2024 | 9 | $68.4K |
| Q2 2024 | 9 | $94.2K |
| Q1 2024 | 7 | $89.4K |
| Q4 2023 | 9 | $124.0K |
| Q3 2023 | 9 | $175.9K |
| Q2 2023 | 13 | $423.6K |
| Q1 2023 | 8 | $114.0K |
| Q4 2022 | 5 | $19.2K |
| Q3 2022 | 9 | $123.0K |
| Q2 2022 | 3 | $66.0K |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Aclarion, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Virtu Financial LLC | 115,183 | $38.0K | 0.00% | +115,183 | New |
| Captrust Financial Advisors | 98,436 | $32.4K | 0.00% | −375,990−79.3% | Reduced |
| HRT Financial LP | 28,639 | $9.00K | 0.00% | +2,428+9.3% | Added |
| Citadel Advisors LLC | 24,849 | $8.19K | 0.00% | −2,813−10.2% | Reduced |
| Tower Research Capital LLC (TRC) | 5,372 | $1.77K | 0.00% | −7,913−59.6% | Reduced |
| Bank of America Corp | 100 | $33 | 0.00% | +100 | New |
| Wells Fargo & Company | 14 | $5 | 0.00% | −27−65.9% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −31,316−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −23,033−100.0% | Sold out |
| State Street Corp | 0 | $0 | 0.00% | −15,801−100.0% | Sold out |
| Whittier Trust Co | 0 | $0 | 0.00% | −9,640−100.0% | Sold out |